These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3245471)

  • 1. [A new anti-arrhythmia drug. I. Study of the anti-arrhythmia effects of a new N-acyl derivative of procainamide in rabbits].
    Kusowska J
    Acta Pol Pharm; 1988; 45(4):346-50. PubMed ID: 3245471
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new anti-arrhythmia drug. II. Comparative studies of the effects of a new acyl derivative of procainamide, procainamide and N-acetylprocainamide on blood pressure and the electrocardiogram in rabbits].
    Kusowska J
    Acta Pol Pharm; 1989; 46(1):90-7. PubMed ID: 2479226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New anti-arrhythmia drug. III. Comparative studies of the effects of N-propionylprocainamide, procainamide and N-acetylprocainamide on hemodynamics and cardiac blood flow].
    Kusowska J; Polakowski P
    Acta Pol Pharm; 1989; 46(2):187-94. PubMed ID: 2483600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of novocainamide on the course of experimental myocardial infarct with arrhythmias in rabbits].
    Marshutina NV
    Farmakol Toksikol; 1980; 43(1):55-9. PubMed ID: 7379992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Brevikarin dihydrochloride--a new original anti-arrhythmia agent].
    Denisenko PP; Vinogradova TV; Semenov AA
    Farmakol Toksikol; 1988; 51(2):50-3. PubMed ID: 3378605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preliminary evaluation of the anti-arrhythmia effect of 4-acylamino-N[2-diethylaminoethyl]benzamides (N-acyl derivatives of procainamide)].
    Kusowska J; Sienkiewicz J
    Acta Pol Pharm; 1985; 42(4):367-73. PubMed ID: 2422880
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparison of the effects of disopyramide, dihydroquinidine and procainamide on 2 types of ventricular arrhythmias].
    Cosnier D; Grimal J; Duchene-Marullaz P
    Therapie; 1971; 26(1):97-107. PubMed ID: 5554772
    [No Abstract]   [Full Text] [Related]  

  • 8. [The effect of sodium salicylate and phenobarbital on the anti-arrhythmia properties of novocainamide and acetylnovocainamide].
    Beregovaia EG; Gorchakova NA; Dunaev VV; Chekman IS
    Eksp Klin Farmakol; 1992; 55(5):30-3. PubMed ID: 1284816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experimental arrhythmia and its prevention].
    Stazhadze LL; Ventslavskaia TA; Korzhova VV
    Kosm Biol Aviakosm Med; 1985; 19(6):64-8. PubMed ID: 4087865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative study of the antiarrhythmic action of bonnecor and the mesidide derivatives of alpha-azacycloalkane carboxylic acids].
    Paliani-Katsitadze NSh; Berdiaev SIu; Turilova AI; Kaverina NV; Likhosherstov AM
    Eksp Klin Farmakol; 1994; 57(3):15-7. PubMed ID: 8049618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia].
    Bracchetti D; Mantovani B; Naccarella F; Lombardi G; Palmieri M
    Boll Soc Ital Cardiol; 1980; Suppl():117-23. PubMed ID: 7349604
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of lithium hydroxybutyrate and lithium chloride on heart rhythm disorders of various origins].
    Galenko-Iaroshevskiĭ PA; Shadurskiĭ KS; Tikhonov AV
    Farmakol Toksikol; 1984; 47(4):54-9. PubMed ID: 6090202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-arrhythmia activity of fusaric acid N,N-diethylaminoethylamide in experimental arrhythmia models in comparison with novocainamide].
    Savina MD; Kudrin AN
    Farmakol Toksikol; 1982; 45(2):63-5. PubMed ID: 7075754
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative evaluation of procainamide and its main metabolite, N-acetylprocainamide, in the acute treatment of ventricular arrhythmias [proceedings].
    Karlsson E; Sonnhag C
    Br J Clin Pharmacol; 1977 Oct; 4(5):632P. PubMed ID: 911617
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of metabolic agents on the antiarrhythmic activity of novocainamide and acetylnovocainamide].
    Beregovaia EG; Gorchakova NA; Samarskaia TG; Dunaev VV; Chekman IS
    Farmakol Toksikol; 1990; 53(5):34-7. PubMed ID: 1701394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sematilide. CK 1752, CK 1752A, ZK 110516.
    Drugs R D; 1999 Apr; 1(4):322-6. PubMed ID: 10566054
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antiarrhythmic effect of beta-N-hexamethyleneimino-para-butoxypropiophenone (TG-17), novocainamide and quinidine in cardiac arrhythmias evoked by strophanthin K in cats].
    Ammar EM; Kudrin AN
    Farmakol Toksikol; 1969; 32(5):566-70. PubMed ID: 5364670
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical pharmacology of procainamide and its active metabolite -N-acetylprocainamide].
    Matusewicz W; Orszulak DE
    Przegl Lek; 1984; 41(5):379-83. PubMed ID: 6206523
    [No Abstract]   [Full Text] [Related]  

  • 19. Resin hemoperfusion for severe N-acetylprocainamide toxicity in patients with renal failure.
    Raja R; Kramer M; Alvis R; Goldstein S; DeLosAngeles A
    Trans Am Soc Artif Intern Organs; 1984; 30():18-20. PubMed ID: 6085435
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological treatment of arrhythmia].
    Kuch J
    Pol Tyg Lek; 1983 Jan; 38(3):103-8. PubMed ID: 6135199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.